Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
a study on HIV/AIDS
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- Sulggi Lee
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Sulggi Lee
Although antiretroviral therapy (ART) decreases HIV-associated mortality, it does not fully restore health. My current research aims to tackle this dilemma via two approaches: (1) identify ways to reduce inflammation and immune activation during treated HIV disease and (2) reduce the size of the HIV reservoir to minimize the negative immunologic consequences related to chronic, persistent HIV.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT02656511
- Phase
- Phase 4
- Study Type
- Interventional
- Last Updated